Abstract
The survival rate of esophageal squamous cell cancer (ESCC) patients is still dismal. Therefore, novel prognostic biomarkers are critically needed for patients with ESCC. SLC9A9 has been reported to be downregulated in hormone-sensitive prostate cancer; however, the correlations between SLC9A9 and ESCC prognosis are unclear. The aim of this study is to evaluate the expression and prognostic significance of SLC9A9 in resectable ESCC. Fresh frozen or paraffin-embedded samples were collected from 167 or 59 patients with resectable ESCC, respectively. The expression of SLC9A9 was assessed by reverse transcription and quantitative real-time polymerase chain reaction analysis (167 patients) and immunohistochemistry (61 patients). The expression of SLC9A9 was not associated with patient clinicopathological characteristics at both transcription and protein levels. The 5-year overall survival in the high SLC9A9 messenger RNA (mRNA) group (n = 106) was poorer than that in the low expression group (n = 61) (34.6 vs. 65.9 %, P < 0.001). Notably, higher SLC9A9 protein expression was also correlated with lower 5-year overall survival (33.1 vs. 66.5 %, P = 0.023). Moreover, multivariate analysis revealed that SLC9A9 mRNA (HR, 2.41; 95 % CI, 1.47–3.97; P = 0.001) and protein (HR, 2.31; 95 %CI, 1.06–5.02; P = 0.034) were independent prognostic factors. In conclusion, the expression of SLC9A9 can be a prognostic predictor for ESCC.
Similar content being viewed by others
References
Siegel R, Ma J, Zou Z, Jemal A. CA Cancer J Clin. 2014;64(1):9–29.
Enzinger PC, Mayer RJ. N Engl J Med. 2003;349(23):2241–52.
Orlowski J, Grinstein S. Pflugers Arch. 2004;447(5):549–65.
Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W, et al. Cancer Res. 2007;67(11):5117–25.
Ng D, Hu N, Hu Y, Wang C, Giffen C, Tang ZZ, et al. Int J Cancer. 2008;123(7):1610–5.
Harguindey S, Orive G, Luis PJ, Paradiso A, Reshkin SJ. Biochim Biophys Acta. 2005;1756(1):1–24.
Liu J, Hu Y, Xie X, Fu J. Ann Thorac Surg. 2012;93(2):423–7.
Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, Andre S, et al. Ann Surg Oncol. 2006;13(7):999–1009.
Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, et al. Dis Esophagus. 2009;22(1):1–8.
Xu XL, Zheng WH, Fu ZX, Li ZP, Xie HX, Li XX, et al. Med Oncol. 2015;32(1):396.
Ma S, Zhao X. Oncol Rep. 2014;32(4):1631–7.
Zhang JY, Bai CY, Bai YQ, Zhang JY, Wu ZY, Wang SH, et al. Hum Pathol. 2014;45(10):2014–22.
Zhang W, Zhu H, Liu X, Wang Q, Zhang X, He J, et al. Ann Thorac Surg. 2014;98(2):513–9.
Shibata-Kobayashi S, Yamashita H, Okuma K, Shiraishi K, Igaki H, Ohtomo K, et al. Oncol Lett. 2013;5(3):903–10.
Xu XL, Zheng WH, Tao KY, Li XX, Xu WZ, Wang Y, et al. Med Oncol. 2014;31(11):257.
Zhao J, Li L, Wei S, Gao Y, Chen Y, Wang G, et al. Dis Esophagus. 2012;25(6):520–6.
Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, et al. Genes Dev. 1997;11(6):701–13.
Mamidipudi V, Cartwright CA. Oncogene. 2009;28(50):4421–33.
Dhanasekaran DN, Reddy EP. Oncogene. 2008;27(48):6245–51.
Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z. Mol Cell. 2005;19(3):309–20.
Lin X, Sikkink RA, Rusnak F, Barber DL. J Biol Chem. 1999;274(51):36125–31.
Kiely PA, Sant A, O’Connor R. J Biol Chem. 2002;277(25):22581–9.
Lin X, Sikkink RA, Rusnak F, Barber DL. J Biol Chem. 1999;274(51):36125–31.
Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, et al. Science. 1999;284(5412):339–43.
Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. Mol Cell Biol. 2001;21(3):893–901.
West KA, Castillo SS, Dennis PA. Drug Resist Updat. 2002;5(6):234–48.
Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. Oncogene. 2003;22(56):8983–98.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Junying Chen, Jing Wen and Yuzhen Zheng contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, J., Wen, J., Zheng, Y. et al. Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma. Tumor Biol. 36, 6797–6803 (2015). https://doi.org/10.1007/s13277-015-3392-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-015-3392-4